Global RNA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2301010140 | Category: Pharma & Healthcare | Pages: 110 | Format: PDF | Published Date: January 31,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global RNA Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global RNA Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global RNA Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global RNA Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global RNA Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global RNA Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories and Arrowhead Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
RNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    siRNA
    ASO
    miRNA
    Nucleic Acid Aptamers
Market segment by Application
    Cancer
    Diabetes
    Tuberculosis
    Cardiovascular Diseases
    Others
Major players covered
    Pfizer
    Roche
    Sanofi-Aventis
    Abbott Laboratories
    Arrowhead Pharmaceuticals
    Benitec Biopharma
    Calimmune Inc
    Dicerna
    Gradalis
    Quark
    RXi
    Senesco
    Silence Therapeutics
    Silenseed
    Tekmira
    Alnylam Pharmaceuticals
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of RNA Drugs, with price, sales, revenue and global market share of RNA Drugs from 2018 to 2023.
Chapter 3, the RNA Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and RNA Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of RNA Drugs.
Chapter 14 and 15, to describe RNA Drugs sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of RNA Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global RNA Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 siRNA
        1.3.3 ASO
        1.3.4 miRNA
        1.3.5 Nucleic Acid Aptamers
    1.4 Market Analysis by Application
        1.4.1 Overview: Global RNA Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Cancer
        1.4.3 Diabetes
        1.4.4 Tuberculosis
        1.4.5 Cardiovascular Diseases
        1.4.6 Others
    1.5 Global RNA Drugs Market Size & Forecast
        1.5.1 Global RNA Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global RNA Drugs Sales Quantity (2018-2029)
        1.5.3 Global RNA Drugs Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer RNA Drugs Product and Services
        2.1.4 Pfizer RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments/Updates
    2.2 Roche
        2.2.1 Roche Details
        2.2.2 Roche Major Business
        2.2.3 Roche RNA Drugs Product and Services
        2.2.4 Roche RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Roche Recent Developments/Updates
    2.3 Sanofi-Aventis
        2.3.1 Sanofi-Aventis Details
        2.3.2 Sanofi-Aventis Major Business
        2.3.3 Sanofi-Aventis RNA Drugs Product and Services
        2.3.4 Sanofi-Aventis RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Sanofi-Aventis Recent Developments/Updates
    2.4 Abbott Laboratories
        2.4.1 Abbott Laboratories Details
        2.4.2 Abbott Laboratories Major Business
        2.4.3 Abbott Laboratories RNA Drugs Product and Services
        2.4.4 Abbott Laboratories RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Abbott Laboratories Recent Developments/Updates
    2.5 Arrowhead Pharmaceuticals
        2.5.1 Arrowhead Pharmaceuticals Details
        2.5.2 Arrowhead Pharmaceuticals Major Business
        2.5.3 Arrowhead Pharmaceuticals RNA Drugs Product and Services
        2.5.4 Arrowhead Pharmaceuticals RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
    2.6 Benitec Biopharma
        2.6.1 Benitec Biopharma Details
        2.6.2 Benitec Biopharma Major Business
        2.6.3 Benitec Biopharma RNA Drugs Product and Services
        2.6.4 Benitec Biopharma RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Benitec Biopharma Recent Developments/Updates
    2.7 Calimmune Inc
        2.7.1 Calimmune Inc Details
        2.7.2 Calimmune Inc Major Business
        2.7.3 Calimmune Inc RNA Drugs Product and Services
        2.7.4 Calimmune Inc RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Calimmune Inc Recent Developments/Updates
    2.8 Dicerna
        2.8.1 Dicerna Details
        2.8.2 Dicerna Major Business
        2.8.3 Dicerna RNA Drugs Product and Services
        2.8.4 Dicerna RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Dicerna Recent Developments/Updates
    2.9 Gradalis
        2.9.1 Gradalis Details
        2.9.2 Gradalis Major Business
        2.9.3 Gradalis RNA Drugs Product and Services
        2.9.4 Gradalis RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Gradalis Recent Developments/Updates
    2.10 Quark
        2.10.1 Quark Details
        2.10.2 Quark Major Business
        2.10.3 Quark RNA Drugs Product and Services
        2.10.4 Quark RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Quark Recent Developments/Updates
    2.11 RXi
        2.11.1 RXi Details
        2.11.2 RXi Major Business
        2.11.3 RXi RNA Drugs Product and Services
        2.11.4 RXi RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 RXi Recent Developments/Updates
    2.12 Senesco
        2.12.1 Senesco Details
        2.12.2 Senesco Major Business
        2.12.3 Senesco RNA Drugs Product and Services
        2.12.4 Senesco RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Senesco Recent Developments/Updates
    2.13 Silence Therapeutics
        2.13.1 Silence Therapeutics Details
        2.13.2 Silence Therapeutics Major Business
        2.13.3 Silence Therapeutics RNA Drugs Product and Services
        2.13.4 Silence Therapeutics RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Silence Therapeutics Recent Developments/Updates
    2.14 Silenseed
        2.14.1 Silenseed Details
        2.14.2 Silenseed Major Business
        2.14.3 Silenseed RNA Drugs Product and Services
        2.14.4 Silenseed RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Silenseed Recent Developments/Updates
    2.15 Tekmira
        2.15.1 Tekmira Details
        2.15.2 Tekmira Major Business
        2.15.3 Tekmira RNA Drugs Product and Services
        2.15.4 Tekmira RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Tekmira Recent Developments/Updates
    2.16 Alnylam Pharmaceuticals
        2.16.1 Alnylam Pharmaceuticals Details
        2.16.2 Alnylam Pharmaceuticals Major Business
        2.16.3 Alnylam Pharmaceuticals RNA Drugs Product and Services
        2.16.4 Alnylam Pharmaceuticals RNA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: RNA Drugs by Manufacturer
    3.1 Global RNA Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global RNA Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global RNA Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of RNA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 RNA Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 RNA Drugs Manufacturer Market Share in 2022
    3.5 RNA Drugs Market: Overall Company Footprint Analysis
        3.5.1 RNA Drugs Market: Region Footprint
        3.5.2 RNA Drugs Market: Company Product Type Footprint
        3.5.3 RNA Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global RNA Drugs Market Size by Region
        4.1.1 Global RNA Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global RNA Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global RNA Drugs Average Price by Region (2018-2029)
    4.2 North America RNA Drugs Consumption Value (2018-2029)
    4.3 Europe RNA Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific RNA Drugs Consumption Value (2018-2029)
    4.5 South America RNA Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa RNA Drugs Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global RNA Drugs Sales Quantity by Type (2018-2029)
    5.2 Global RNA Drugs Consumption Value by Type (2018-2029)
    5.3 Global RNA Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global RNA Drugs Sales Quantity by Application (2018-2029)
    6.2 Global RNA Drugs Consumption Value by Application (2018-2029)
    6.3 Global RNA Drugs Average Price by Application (2018-2029)
7 North America
    7.1 North America RNA Drugs Sales Quantity by Type (2018-2029)
    7.2 North America RNA Drugs Sales Quantity by Application (2018-2029)
    7.3 North America RNA Drugs Market Size by Country
        7.3.1 North America RNA Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America RNA Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe RNA Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe RNA Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe RNA Drugs Market Size by Country
        8.3.1 Europe RNA Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe RNA Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific RNA Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific RNA Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific RNA Drugs Market Size by Region
        9.3.1 Asia-Pacific RNA Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific RNA Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America RNA Drugs Sales Quantity by Type (2018-2029)
    10.2 South America RNA Drugs Sales Quantity by Application (2018-2029)
    10.3 South America RNA Drugs Market Size by Country
        10.3.1 South America RNA Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America RNA Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa RNA Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa RNA Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa RNA Drugs Market Size by Country
        11.3.1 Middle East & Africa RNA Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa RNA Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 RNA Drugs Market Drivers
    12.2 RNA Drugs Market Restraints
    12.3 RNA Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of RNA Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of RNA Drugs
    13.3 RNA Drugs Production Process
    13.4 RNA Drugs Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 RNA Drugs Typical Distributors
    14.3 RNA Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global RNA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?